These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 9097710
21. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Liu M, Lawson G, Delos M, Jamart J, Chatelain B, Remacle M, Marbaix E. Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353 [Abstract] [Full Text] [Related]
23. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis]. Wu X, Zhang Z, Cai S. Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065 [Abstract] [Full Text] [Related]
29. p53, PCNA and Ki67 in laryngeal cancer. Golusiński W, Olofsson J, Szmeja Z, Majewski P. Pol J Pathol; 1996 Jan; 47(4):175-82. PubMed ID: 9097709 [Abstract] [Full Text] [Related]
30. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts. Griffey SM, Kraegel SA, Madewell BR. J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729 [Abstract] [Full Text] [Related]
31. [DNA content, expression of proliferating cell nuclear antigen and surgical margins in locally advanced laryngeal cancer]. Wang B, Xia L, Shi Q. Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Dec; 33(6):361-3. PubMed ID: 11938851 [Abstract] [Full Text] [Related]
32. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions]. Sawada M, Ueda G, Inoue M, Shimizu H, Ogawa H, Nakazawa A, Fujita M, Tanizawa O, Tsujimoto M. Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557 [Abstract] [Full Text] [Related]
33. Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus. Dabrowski A, Szumiło J, Brajerski G, Wallner G. Ann Univ Mariae Curie Sklodowska Med; 2001 Feb; 56():59-67. PubMed ID: 11977365 [Abstract] [Full Text] [Related]
34. Minimal breast cancer: analysis of proliferative activity using a monoclonal antibody to proliferating cell nuclear antigen (PCNA) and its relationship to histological grade and prognosis. Lanzafame S, Magro G, Broggi B. Pathologica; 1994 Apr; 86(2):150-6. PubMed ID: 7936757 [Abstract] [Full Text] [Related]
36. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables. Frierson HF. Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204 [Abstract] [Full Text] [Related]
37. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ. J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [Abstract] [Full Text] [Related]
38. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Dong Y, Sui L, Tai Y, Sugimoto K, Hirao T, Tokuda M. Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240 [Abstract] [Full Text] [Related]
39. Cell proliferation and tumor angiogenesis in oral squamous cell carcinoma. Alcalde RE, Shintani S, Yoshihama Y, Matsumura T. Anticancer Res; 1995 Nov; 15(4):1417-22. PubMed ID: 7544566 [Abstract] [Full Text] [Related]
40. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer. Yoshimatsu T, Uramoto H, Oyama T, Yashima Y, Gu C, Morita M, Sugio K, Kohno K, Yasumoto K. Anticancer Res; 2005 Nov; 25(5):3437-43. PubMed ID: 16101161 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]